Get Premium to unlock powerful stock data
BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

$ 13.85 +0.11 (+0.8%) 10:07 AM EST
P/E:
At Loss
P/B:
1.82
Market Cap:
$ 382.98M
Enterprise V:
$ 185.41M
Volume:
68.20K
Avg Vol (2M):
1.03M
Also Trade In:
Volume:
68.20K
Market Cap $:
382.98M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.03M
Enterprise Value $:
185.41M
PB Ratio:
1.82
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

BioXcel Therapeutics Inc
NAICS : 325412 SIC : 2834
555 Long Wharf Drive, 12th Floor, New Haven, CT, USA, 06511
Description
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
Name Current Vs Industry Vs History
Cash-To-Debt 151.04
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -133
3-Year EPS without NRI Growth Rate -135.5
3-Year FCF Growth Rate -176.8
Name Current Vs Industry Vs History
5-Day RSI 68.57
9-Day RSI 56.08
14-Day RSI 49.98
6-1 Month Momentum % -41.21
12-1 Month Momentum % -49.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.98
Quick Ratio 12.93
Cash Ratio 12.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.1

Financials (Next Earnings Date:2022-08-10 Est.)

BTAI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BTAI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -4.12
Beta 0.23
Volatility % 44.69
14-Day RSI 49.98
14-Day ATR ($) 1.443013
20-Day SMA ($) 12.957
12-1 Month Momentum % -49.82
52-Week Range ($) 9.08 - 38.9994
Shares Outstanding (Mil) 27.99

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioXcel Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More